Immunotherapy with the Vaccine Based On the Canine Neurotropic Virus (CIMT-54) For the Treatment of Cancer

Abstract

• Page 1 of 8 • Citation: Segura-Puello HR, Charry JSS, Muñoz-Forero DM, Mosquera DJN, Villamil-Ballesteros AC (2019) Immunotherapy with the Vaccine Based On the Canine Neurotropic Virus (CIMT-54) For the Treatment of Cancer. Int J Oncol Res 2:018. doi.org/10.23937/2643-4563/1710018 Accepted: October 14, 2019; Published: October 16, 2019 Copyright: © 2019 Segura-Puello HR, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.